Cargando…
Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127947/ https://www.ncbi.nlm.nih.gov/pubmed/25749121 http://dx.doi.org/10.1186/2045-7022-4-S3-O1 |
| _version_ | 1782330088261419008 |
|---|---|
| author | Valeyrie-Allanore, Laurence Mockenhaupt, Maja Sekula, Peggy Berrehar, François Ortonne, Nicolas Assier, Haudrey Goujon, Colette Bagot, Martine Roujeau, Jean-Claude Bensussan, Armand Le Gouvello, Sabine |
| author_facet | Valeyrie-Allanore, Laurence Mockenhaupt, Maja Sekula, Peggy Berrehar, François Ortonne, Nicolas Assier, Haudrey Goujon, Colette Bagot, Martine Roujeau, Jean-Claude Bensussan, Armand Le Gouvello, Sabine |
| author_sort | Valeyrie-Allanore, Laurence |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4127947 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41279472014-08-14 Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients Valeyrie-Allanore, Laurence Mockenhaupt, Maja Sekula, Peggy Berrehar, François Ortonne, Nicolas Assier, Haudrey Goujon, Colette Bagot, Martine Roujeau, Jean-Claude Bensussan, Armand Le Gouvello, Sabine Clin Transl Allergy Oral Presentation BioMed Central 2014-07-18 /pmc/articles/PMC4127947/ /pubmed/25749121 http://dx.doi.org/10.1186/2045-7022-4-S3-O1 Text en Copyright © 2014 Valeyrie-Allanore et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Valeyrie-Allanore, Laurence Mockenhaupt, Maja Sekula, Peggy Berrehar, François Ortonne, Nicolas Assier, Haudrey Goujon, Colette Bagot, Martine Roujeau, Jean-Claude Bensussan, Armand Le Gouvello, Sabine Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients |
| title | Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients |
| title_full | Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients |
| title_fullStr | Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients |
| title_full_unstemmed | Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients |
| title_short | Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients |
| title_sort | mechanisms that limit proliferative potential of drug-specific ltt in drug-induced severe cutaneous adverse reaction patients |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127947/ https://www.ncbi.nlm.nih.gov/pubmed/25749121 http://dx.doi.org/10.1186/2045-7022-4-S3-O1 |
| work_keys_str_mv | AT valeyrieallanorelaurence mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT mockenhauptmaja mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT sekulapeggy mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT berreharfrancois mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT ortonnenicolas mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT assierhaudrey mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT goujoncolette mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT bagotmartine mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT roujeaujeanclaude mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT bensussanarmand mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients AT legouvellosabine mechanismsthatlimitproliferativepotentialofdrugspecificlttindruginducedseverecutaneousadversereactionpatients |